The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections
Open accessAbstract
INTRODUCTION: Dengue virus (DENV) infection is currently a major cause of morbidity and mortality in the world; it has become more common and virulent over the past half-century and has gained much attention. Thus, this review compared the percentage of severe cases of both primary and secondary infections with different serotypes of dengue virus. METHODS: Data related to the number of cases involving dengue fever (DF), dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS) or severe dengue infections caused by different serotypes of dengue virus were obtained by using the SCOPUS, the PUBMED and the OVID search engines with the keywords "(dengue* OR dengue virus*) AND (severe dengue* OR severity of illness index* OR severity* OR DF* OR DHF* OR DSS*) AND (serotypes* OR serogroup*)", according to the MESH terms suggested by PUBMED and OVID. RESULTS: Approximately 31 studies encompassing 15,741 cases reporting on the dengue serotypes together with their severity were obtained, and meta-analysis was carried out to analyze the data. This study found that DENV-3 from the Southeast Asia (SEA) region displayed the greatest percentage of severe cases in primary infection (95% confidence interval (CI), 31.22-53.67, 9 studies, n = 598, I2 = 71.53%), whereas DENV-2, DENV-3, and DENV-4 from the SEA region, as well as DENV-2 and DENV-3 from non-SEA regions, exhibited the greatest percentage of severe cases in secondary infection (95% CI, 11.64-80.89, 4-14 studies, n = 668-3,149, I2 = 14.77-96.20%). Moreover, DENV-2 and DENV-4 from the SEA region had been found to be more highly associated with dengue shock syndrome (DSS) (95% CI, 10.47-40.24, 5-8 studies, n = 642-2,530, I2 = 76.93-97.70%), while DENV-3 and DENV-4 from the SEA region were found to be more highly associated with dengue hemorrhagic fever (DHF) (95% CI, 31.86-54.58, 9 studies, n = 674-2,278, I2 = 55.74-88.47%), according to the 1997 WHO dengue classification. Finally, DENV-2 and DENV-4 from the SEA region were discovered to be more highly associated with secondary infection compared to other serotypes (95% CI, 72.01-96.32, 9-12 studies, n = 671-2,863, I2 = 25.01-96.75%). CONCLUSION: This study provides evidence that the presence of certain serotypes, including primary infection with DENV-3 from the SEA region and secondary infection with DENV-2, DENV-3, and DENV-4 also from the SEA region, as well as DENV-2 and DENV-3 from non SEA regions, increased the risk of severe dengue infections. Thus, these serotypes are worthy of special consideration when making clinical predictions upon the severity of the infection. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42015026093 (http://www.crd.york.ac.uk/PROSPERO).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 1×
“It is in fact, endemic in over 100 countries in Africa, America, and Asia, with 390 million new dengue fever infections [1] and approximately 12,000 deaths occurring worldwide every year [2].”
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Robinson, M., Shipton, D., Walsh, D., Whyte, B., & McCartney, G. (2015) · BMC Public Health · doi:10.1186/1471-2458-15-1 · Cited by 696
SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999
NISALAK, A., ENDY, T. P., NIMMANNITYA, S., KALAYANAROOJ, S., THISAYAKORN, U., SCOTT, R. M., BURKE, D. S., HOKE, C. H., INNIS, B. L., & VAUGHN, D. W. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.191 · Cited by 398
Endy, T. P., Nisalak, A., Chunsuttitwat, S., Vaughn, D. W., Green, S., Ennis, F. A., Rothman, A. L., & Libraty, D. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/382280 · Cited by 340
Epidemiologic Studies on Dengue in Santiago de Cuba, 1997
Guzman, M. G. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.9.793 · Cited by 320
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever
Watts, D. M., Porter, K. R., Putvatana, P., Vasquez, B., Calampa, C., Hayes, C. G., & Halstead, S. B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04015-5 · Cited by 306
Sterne, J. A. C., Bradburn, M. J., & Egger, M. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch18 · Cited by 297
Kang, D.-H., Anderson, S., Kim, Y.-G., Mazzalli, M., Suga, S.-I., Jefferson, J. A., Gordon, K. L., Oyama, T. T., Hughes, J., Hugo, C., et al. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80019-6 · Cited by 285
Phylogenetic Relationships and Differential Selection Pressures among Genotypes of Dengue-2 Virus
Twiddy, S. S., Farrar, J. J., Vinh Chau, N., Wills, B., Gould, E. A., Gritsun, T., Lloyd, G., & Holmes, E. C. (2002) · Virology · doi:10.1006/viro.2002.1447 · Cited by 273
Cited by
Harapan, H., Michie, A., Sasmono, R. T., & Imrie, A. (2020) · Viruses · doi:10.3390/v12080829 · Cited by 360
Paz-Bailey, G., Adams, L. E., Deen, J., Anderson, K. B., & Katzelnick, L. C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02576-x · Cited by 346
Tricou, V., Yu, D., Reynales, H., Biswal, S., Saez-Llorens, X., Sirivichayakul, C., Lopez, P., Borja-Tabora, C., Bravo, L., Kosalaraksa, P., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00522-3 · Cited by 268
Metadata
- Authors
- Soo, K.-M., Khalid, B., Ching, S.-M., & Chee, H.-Y.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-05-23
- Volume
- 11
- Issue
- 5
- Pages
- e0154760
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2399399246
- Cited by
- 292
- References
- 38
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.